2nd Academic CML-CAB

On 11 June 2023, we were able to bring together world-leading patient advocates, researchers, and clinicians to jointly explore the barriers and opportunities of research towards new pathways to cure CML in our 2nd Academic CML-CAB meeting held in Frankfurt / Germany....

CML Community Advisory Board (CML-CAB) Meeting 2021

CML Community Advisory Board (CML-CAB) Meeting 2021 On 18 February 2021, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted it´s first meeting of the year. It was the 12th CML Community Advisory Board (CML-CAB) and 22nd...

CML-CAB Resources

CML-CAB Meetings: Based on the proven ECAB model implemented by the HIV patient community and EATG for more than a decade, the first CML-CAB was held in May 2016. Since then, we have carried out 13 CML Community Advisory Boards in 24 sessions (2016-2023). 13 CML-CABs...

CML-CAB Objectives & Strategy

CML-CAB Objectives & Strategy   The CML-CAB objectives are: Providing researchers, academics, government, policy makers, authorities and the pharmaceutical industry with advice and input on different issues that impact on patients’ lives Promoting...

Composition of CML-CAB

Composition of CML-CAB CML-CAB Chairs Bahija Gouimi (Morocco)      CML advocacy years: 22No. of CMLHZ attended: 16 Gerald Clements (USA)      CML advocacy years: 23No. of CMLHZ attended: 8 CML-CAB Management Denis Costello (Spain)    CML advocacy years: 15No. of CMLHZ...

How do CABs work?

How do CABs work?   CML-CAB invites participants from the companies CML-CAB sets the agenda for a two-way dialogue and pick the topics that are most meaningful to us CML-CAB respects confidentiality to have a trusted and open dialogue CML-CAB reports to...